Literature DB >> 18606464

In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.

Craig R Rees1, Joshua M Costin, Ryan C Fink, Matthew McMichael, Krystal A Fontaine, Sharon Isern, Scott F Michael.   

Abstract

The anti-adhesive compound p-sulfoxy-cinnamic acid, zosteric acid (ZA), is derived from the temperate marine eelgrass, Zostera marina. ZA and five combinatorial chemistries based on ZA were evaluated for their anti-viral properties against dengue virus in a focus forming unit reduction assay. None of the compounds showed evidence of toxicity to the monkey kidney cell line LLCMK-2 over the concentration ranges tested. ZA showed a modest IC(50) of approximately 2.3 mM against DENV-2. Three other compounds showed IC(50) values of 2.5, 2.4, 0.3 mM, with a fourth not achieving a 50% inhibitory concentration against DENV-2. The most active compound, CF 238, showed IC(50) values of 24, 46, 14 and 47 microM against DENV-1, DENV-2, DENV-3 and DENV-4, respectively. CF 238 showed evidence of inhibition at an entry step in the viral life cycle and enhanced virus:cell binding as evidenced by a quantitative RT-PCR assay system. CF 238 may promote inappropriate virus:cell attachments common to all DENV strains that interfere with receptor interactions required for viral entry. These and other related chemistries may be useful as reagents for studying DENV entry, capturing and detecting DENV, and development of pharmaceuticals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606464     DOI: 10.1016/j.antiviral.2008.05.007

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  13 in total

Review 1.  Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies.

Authors:  Daniel K Afosah; Rami A Al-Horani
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

2.  Structural optimization and de novo design of dengue virus entry inhibitory peptides.

Authors:  Joshua M Costin; Ekachai Jenwitheesuk; Shee-Mei Lok; Elizabeth Hunsperger; Kelly A Conrads; Krystal A Fontaine; Craig R Rees; Michael G Rossmann; Sharon Isern; Ram Samudrala; Scott F Michael
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

3.  Dengue virus entry as target for antiviral therapy.

Authors:  Marijke M F Alen; Dominique Schols
Journal:  J Trop Med       Date:  2012-03-04

Review 4.  Progress in the identification of dengue virus entry/fusion inhibitors.

Authors:  Carolina De La Guardia; Ricardo Lleonart
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

Review 5.  Peptides as Therapeutic Agents for Dengue Virus.

Authors:  Miaw-Fang Chew; Keat-Seong Poh; Chit-Laa Poh
Journal:  Int J Med Sci       Date:  2017-10-15       Impact factor: 3.738

6.  In silico prediction of monovalent and chimeric tetravalent vaccines for prevention and treatment of dengue fever.

Authors:  Vijayakumar Subramaniyan; Ramesh Venkatachalam; Prabhu Srinivasan; Manogar Palani
Journal:  J Biomed Res       Date:  2017-11-01

7.  Anticonvulsant Activity of Halogen-Substituted Cinnamic Acid Derivatives and Their Effects on Glycosylation of PTZ-Induced Chronic Epilepsy in Mice.

Authors:  Ye Cuan; Xirui He; Yuhui Zhao; Jiajun Yang; Yajun Bai; Yin Sun; Qiang Zhang; Zefeng Zhao; Xiaoyang Wei; Xiaohui Zheng
Journal:  Molecules       Date:  2017-12-29       Impact factor: 4.411

Review 8.  Potential Medicinal Plants for the Treatment of Dengue Fever and Severe Acute Respiratory Syndrome-Coronavirus.

Authors:  Mohammed S M Saleh; Yusof Kamisah
Journal:  Biomolecules       Date:  2020-12-30

Review 9.  Potential anti-dengue medicinal plants: a review.

Authors:  Siti Latifah Abd Kadir; Harisun Yaakob; Razauden Mohamed Zulkifli
Journal:  J Nat Med       Date:  2013-04-17       Impact factor: 2.343

Review 10.  Production, Transmission, Pathogenesis, and Control of Dengue Virus: A Literature-Based Undivided Perspective.

Authors:  Muhammad Torequl Islam; Cristina Quispe; Jesús Herrera-Bravo; Chandan Sarkar; Rohit Sharma; Neha Garg; Larry Ibarra Fredes; Miquel Martorell; Mohammed M Alshehri; Javad Sharifi-Rad; Sevgi Durna Daştan; Daniela Calina; Radi Alsafi; Saad Alghamdi; Gaber El-Saber Batiha; Natália Cruz-Martins
Journal:  Biomed Res Int       Date:  2021-12-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.